Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-02 · accession 0001061983-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-02 | 2025-12-02 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $10.00 | +8,750 | 83.3K | +12% | +$87.5K |
| D | 2025-12-02 | 2025-12-02 | CYTK | HENDERSON JOHN T | Dir | S - Sale+OE | $63.90 | -8,750 | 74.6K | -11% | -$559.1K |
| D | 2025-12-02 | 2025-12-02 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $0.00 | -8,750 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | M | A | 8,750 | $10.00 | 83,328 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-02 | S | D | 8,750 | $63.90 | 74,578 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-02 | M | D | 8,750 | $0.00 | 0 | D | $10.00 · 2016-02-04 to 2026-01-04 | 8,750 Common Stock |